Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97264609 |
2 | regulation of sequestering of triglyceride (GO:0010889) | 4.96459711 |
3 | negative regulation of cell killing (GO:0031342) | 4.77162075 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.77162075 |
5 | neutrophil activation involved in immune response (GO:0002283) | 4.59599705 |
6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.43711404 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.35167863 |
8 | modulation by symbiont of host defense response (GO:0052031) | 4.35167863 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.35167863 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.35167863 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.35167863 |
12 | modulation by symbiont of host immune response (GO:0052553) | 4.35167863 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32750919 |
14 | detection of other organism (GO:0098543) | 4.27178810 |
15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.05144900 |
16 | detection of bacterium (GO:0016045) | 4.05130595 |
17 | low-density lipoprotein particle clearance (GO:0034383) | 4.03721224 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.96971284 |
19 | fatty acid transmembrane transport (GO:1902001) | 3.90002349 |
20 | detection of molecule of bacterial origin (GO:0032490) | 3.83811772 |
21 | detection of external biotic stimulus (GO:0098581) | 3.81681737 |
22 | response to peptidoglycan (GO:0032494) | 3.80354008 |
23 | negative regulation of granulocyte differentiation (GO:0030853) | 3.73974951 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.71322619 |
25 | carnitine shuttle (GO:0006853) | 3.60741686 |
26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.59781617 |
27 | cellular extravasation (GO:0045123) | 3.53378385 |
28 | biotin metabolic process (GO:0006768) | 3.52091098 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 3.47898916 |
30 | phospholipid homeostasis (GO:0055091) | 3.46281692 |
31 | B cell receptor signaling pathway (GO:0050853) | 3.35011105 |
32 | leukocyte aggregation (GO:0070486) | 3.31644618 |
33 | valine metabolic process (GO:0006573) | 3.29521357 |
34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.29115321 |
35 | detection of biotic stimulus (GO:0009595) | 3.28803426 |
36 | positive regulation of fatty acid oxidation (GO:0046321) | 3.27699243 |
37 | neutrophil activation (GO:0042119) | 3.27003429 |
38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26040075 |
39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.25253795 |
40 | fatty acid beta-oxidation (GO:0006635) | 3.24128221 |
41 | urea cycle (GO:0000050) | 3.24090100 |
42 | urea metabolic process (GO:0019627) | 3.24090100 |
43 | negative regulation of lipase activity (GO:0060192) | 3.23978875 |
44 | acylglycerol homeostasis (GO:0055090) | 3.23659911 |
45 | triglyceride homeostasis (GO:0070328) | 3.23659911 |
46 | positive regulation of B cell differentiation (GO:0045579) | 3.23170485 |
47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22283386 |
48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21873909 |
49 | plasma lipoprotein particle clearance (GO:0034381) | 3.21064546 |
50 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.19890509 |
51 | positive regulation of lipid catabolic process (GO:0050996) | 3.19384539 |
52 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.18465866 |
53 | complement activation, alternative pathway (GO:0006957) | 3.17987353 |
54 | brown fat cell differentiation (GO:0050873) | 3.15389643 |
55 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.14616292 |
56 | response to host immune response (GO:0052572) | 3.14250218 |
57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14250218 |
58 | triglyceride catabolic process (GO:0019433) | 3.13826479 |
59 | alpha-linolenic acid metabolic process (GO:0036109) | 3.11732722 |
60 | germinal center formation (GO:0002467) | 3.11662128 |
61 | regulation of cholesterol storage (GO:0010885) | 3.11275267 |
62 | response to interleukin-15 (GO:0070672) | 3.05787332 |
63 | fatty acid oxidation (GO:0019395) | 3.05099421 |
64 | lipid oxidation (GO:0034440) | 2.99676943 |
65 | granulocyte activation (GO:0036230) | 2.98660800 |
66 | neutral lipid catabolic process (GO:0046461) | 2.98429336 |
67 | acylglycerol catabolic process (GO:0046464) | 2.98429336 |
68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97702855 |
69 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96989018 |
70 | response to host (GO:0075136) | 2.96989018 |
71 | response to host defenses (GO:0052200) | 2.96989018 |
72 | lipid storage (GO:0019915) | 2.96518409 |
73 | negative regulation of protein autophosphorylation (GO:0031953) | 2.96242373 |
74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.94701707 |
75 | L-phenylalanine catabolic process (GO:0006559) | 2.94701707 |
76 | regulation of mast cell degranulation (GO:0043304) | 2.94369307 |
77 | white fat cell differentiation (GO:0050872) | 2.93904275 |
78 | indole-containing compound catabolic process (GO:0042436) | 2.92531573 |
79 | indolalkylamine catabolic process (GO:0046218) | 2.92531573 |
80 | tryptophan catabolic process (GO:0006569) | 2.92531573 |
81 | homocysteine metabolic process (GO:0050667) | 2.92191699 |
82 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90912801 |
83 | linoleic acid metabolic process (GO:0043651) | 2.90220784 |
84 | aromatic amino acid family catabolic process (GO:0009074) | 2.90146658 |
85 | nitrogen cycle metabolic process (GO:0071941) | 2.89474550 |
86 | immunoglobulin mediated immune response (GO:0016064) | 2.88538404 |
87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88172010 |
88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86429496 |
89 | positive regulation of histone deacetylation (GO:0031065) | 2.86332170 |
90 | myeloid cell activation involved in immune response (GO:0002275) | 2.84100870 |
91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83110313 |
92 | negative regulation of interleukin-12 production (GO:0032695) | 2.82705607 |
93 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.81765547 |
94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81354558 |
95 | acetyl-CoA metabolic process (GO:0006084) | 2.81125337 |
96 | fatty acid catabolic process (GO:0009062) | 2.80749456 |
97 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.79712664 |
98 | positive regulation of lipid storage (GO:0010884) | 2.79269887 |
99 | tryptophan metabolic process (GO:0006568) | 2.79245956 |
100 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78761254 |
101 | negative regulation of lipid storage (GO:0010888) | 2.77548978 |
102 | carnitine transmembrane transport (GO:1902603) | 2.77489416 |
103 | regulation of leukocyte degranulation (GO:0043300) | 2.77392691 |
104 | positive regulation of cholesterol transport (GO:0032376) | 2.76819872 |
105 | positive regulation of sterol transport (GO:0032373) | 2.76819872 |
106 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75970812 |
107 | macrophage activation (GO:0042116) | 2.73145809 |
108 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72698592 |
109 | positive regulation of cholesterol efflux (GO:0010875) | 2.72383522 |
110 | respiratory burst (GO:0045730) | 2.71332431 |
111 | regulation of B cell differentiation (GO:0045577) | 2.68403700 |
112 | positive thymic T cell selection (GO:0045059) | 2.68234619 |
113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67989290 |
114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.66812053 |
115 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65964655 |
116 | microglial cell activation (GO:0001774) | 2.64279775 |
117 | regulation of triglyceride metabolic process (GO:0090207) | 2.64248360 |
118 | amino-acid betaine metabolic process (GO:0006577) | 2.62950260 |
119 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.62490000 |
120 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61770235 |
121 | carnitine transport (GO:0015879) | 2.61227397 |
122 | amino-acid betaine transport (GO:0015838) | 2.61227397 |
123 | kynurenine metabolic process (GO:0070189) | 2.59869577 |
124 | phospholipid efflux (GO:0033700) | 2.59512469 |
125 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.59480687 |
126 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.59480687 |
127 | L-phenylalanine metabolic process (GO:0006558) | 2.58711084 |
128 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.58711084 |
129 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.57051218 |
130 | regulation of protein activation cascade (GO:2000257) | 2.56274025 |
131 | histone H3-K36 demethylation (GO:0070544) | 2.53314004 |
132 | short-chain fatty acid metabolic process (GO:0046459) | 2.51435023 |
133 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.50935659 |
134 | regulation of bile acid biosynthetic process (GO:0070857) | 2.50552678 |
135 | leukocyte degranulation (GO:0043299) | 2.49083075 |
136 | response to muramyl dipeptide (GO:0032495) | 2.48725966 |
137 | growth hormone receptor signaling pathway (GO:0060396) | 2.48474967 |
138 | positive regulation of mast cell activation (GO:0033005) | 2.46616467 |
139 | definitive hemopoiesis (GO:0060216) | 2.45794168 |
140 | regulation of complement activation (GO:0030449) | 2.45188854 |
141 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.44857032 |
142 | protein carboxylation (GO:0018214) | 2.44857032 |
143 | regulation of fatty acid oxidation (GO:0046320) | 2.44463162 |
144 | regulation of granulocyte differentiation (GO:0030852) | 2.43693092 |
145 | intracellular lipid transport (GO:0032365) | 2.43635009 |
146 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42985917 |
147 | negative regulation of humoral immune response (GO:0002921) | 2.42825511 |
148 | acylglycerol biosynthetic process (GO:0046463) | 2.42296748 |
149 | neutral lipid biosynthetic process (GO:0046460) | 2.42296748 |
150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.42152525 |
151 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.41784474 |
152 | monocarboxylic acid catabolic process (GO:0072329) | 2.41504555 |
153 | type I interferon signaling pathway (GO:0060337) | 2.41227559 |
154 | cellular response to type I interferon (GO:0071357) | 2.41227559 |
155 | fatty acid homeostasis (GO:0055089) | 2.40902585 |
156 | regulation of tolerance induction (GO:0002643) | 2.40593267 |
157 | histone H3-K4 trimethylation (GO:0080182) | 2.40449625 |
158 | plasma lipoprotein particle assembly (GO:0034377) | 2.39507842 |
159 | regulation of platelet aggregation (GO:0090330) | 2.39454957 |
160 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.39180440 |
161 | response to type I interferon (GO:0034340) | 2.38908178 |
162 | B cell mediated immunity (GO:0019724) | 2.38895078 |
163 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.38411598 |
164 | lipid homeostasis (GO:0055088) | 2.38163259 |
165 | cellular response to interleukin-15 (GO:0071350) | 2.37930505 |
166 | regulation of necroptotic process (GO:0060544) | 2.37461233 |
167 | negative thymic T cell selection (GO:0045060) | 2.37443001 |
168 | G-protein coupled receptor internalization (GO:0002031) | 2.36537444 |
169 | embryonic process involved in female pregnancy (GO:0060136) | 2.36511536 |
170 | transcytosis (GO:0045056) | 2.35888624 |
171 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.35588279 |
172 | regulation of regulated secretory pathway (GO:1903305) | 2.35535679 |
173 | triglyceride biosynthetic process (GO:0019432) | 2.35166103 |
174 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.35140200 |
175 | megakaryocyte development (GO:0035855) | 2.34846536 |
176 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.34091493 |
177 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.33564868 |
178 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.33564868 |
179 | import into cell (GO:0098657) | 2.32077107 |
180 | regulation of lipid catabolic process (GO:0050994) | 2.32071154 |
181 | negative T cell selection (GO:0043383) | 2.31984293 |
182 | regulation of T cell tolerance induction (GO:0002664) | 2.31924729 |
183 | mannose metabolic process (GO:0006013) | 2.31875735 |
184 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.31856992 |
185 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.31856992 |
186 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31341237 |
187 | I-kappaB phosphorylation (GO:0007252) | 2.31088799 |
188 | negative regulation of complement activation (GO:0045916) | 2.30779605 |
189 | neutrophil mediated immunity (GO:0002446) | 2.30665840 |
190 | positive T cell selection (GO:0043368) | 2.30624057 |
191 | bile acid metabolic process (GO:0008206) | 2.29802906 |
192 | carnitine metabolic process (GO:0009437) | 2.29742526 |
193 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.29250343 |
194 | cholesterol homeostasis (GO:0042632) | 2.28829974 |
195 | branched-chain amino acid metabolic process (GO:0009081) | 2.27335493 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.37694407 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.32606213 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.08490604 |
4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01402810 |
5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88869632 |
6 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84635535 |
7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75044434 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.69836411 |
9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64664330 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.44254000 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35472974 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.34348316 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31508431 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.25583930 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16195069 |
16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12960648 |
17 | SPI1_23127762_ChIP-Seq_K562_Human | 2.09038402 |
18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07846666 |
19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.04805338 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.03059337 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02407029 |
22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98558618 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 1.96825754 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95202188 |
25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.91512477 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.88358479 |
27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87886051 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86456363 |
29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83174639 |
30 | MYC_22102868_ChIP-Seq_BL_Human | 1.81324738 |
31 | MYB_26560356_Chip-Seq_TH1_Human | 1.80290568 |
32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.74208266 |
33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71940211 |
34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71756012 |
35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70699117 |
36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70158994 |
37 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.67700589 |
38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67489828 |
39 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.66552728 |
40 | GATA1_19941826_ChIP-Seq_K562_Human | 1.57384832 |
41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57283371 |
42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55428366 |
43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.55367988 |
44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55347387 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50727328 |
46 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50562234 |
47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49446123 |
48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47544129 |
49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46576997 |
50 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45424905 |
51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43851436 |
52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43090662 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41224533 |
54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39792913 |
55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39607623 |
56 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39402341 |
57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38950614 |
58 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.38016606 |
59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37718550 |
60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37522013 |
61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37240431 |
62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36185769 |
63 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.35221750 |
64 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34794988 |
65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33890018 |
66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32000845 |
67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.31439975 |
68 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31220380 |
69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31174512 |
70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31142010 |
71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31123657 |
72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27297965 |
73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26946254 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26059380 |
75 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25981991 |
76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25848555 |
77 | MAF_26560356_Chip-Seq_TH2_Human | 1.25807684 |
78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25394165 |
79 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25206911 |
80 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24876035 |
81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23780306 |
82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23734713 |
83 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22332289 |
84 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20111311 |
85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19707405 |
86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19488342 |
87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19075439 |
88 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18770979 |
89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17450143 |
90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17295937 |
91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16995588 |
92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16494495 |
93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14935606 |
94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14506391 |
95 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13427613 |
96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.13343040 |
97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13070421 |
98 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12726407 |
99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10468477 |
100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10328389 |
101 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09759752 |
102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08736146 |
103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07735860 |
104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07568071 |
105 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07331351 |
106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07193947 |
107 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.05777943 |
108 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05771861 |
109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04621330 |
110 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03433885 |
111 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03112370 |
112 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02283484 |
113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01762854 |
114 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01168316 |
115 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01069339 |
116 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00555792 |
117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99181726 |
118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99048457 |
119 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98457570 |
120 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98450063 |
121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97797781 |
122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97149541 |
123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97131807 |
124 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96766662 |
125 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96652203 |
126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95934903 |
127 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95896810 |
128 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95892028 |
129 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95803650 |
130 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.95720630 |
131 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95387506 |
132 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94962307 |
133 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94847693 |
134 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94632290 |
135 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94632290 |
136 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94406422 |
137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94402830 |
138 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94028344 |
139 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93986226 |
140 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93685813 |
141 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93671192 |
142 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.93192981 |
143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93146487 |
144 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92719545 |
145 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92665346 |
146 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92565595 |
147 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92111974 |
148 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91736836 |
149 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91297963 |
150 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91074503 |
151 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90658086 |
152 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90271798 |
153 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.89908707 |
154 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89845129 |
155 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89577372 |
156 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89151418 |
157 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.88790956 |
158 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.88122781 |
159 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86985525 |
160 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86897421 |
161 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86720727 |
162 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86502730 |
163 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.85986130 |
164 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.85645232 |
165 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.85114624 |
166 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84262087 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 4.77436035 |
2 | MP0005360_urolithiasis | 3.97979863 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.75864319 |
4 | MP0005365_abnormal_bile_salt | 3.66665887 |
5 | MP0005666_abnormal_adipose_tissue | 3.05415072 |
6 | MP0005085_abnormal_gallbladder_physiolo | 2.96825782 |
7 | MP0010329_abnormal_lipoprotein_level | 2.77595191 |
8 | MP0004130_abnormal_muscle_cell | 2.72013514 |
9 | MP0004185_abnormal_adipocyte_glucose | 2.68352245 |
10 | MP0003252_abnormal_bile_duct | 2.60011321 |
11 | MP0002971_abnormal_brown_adipose | 2.39004342 |
12 | MP0005451_abnormal_body_composition | 2.29172265 |
13 | MP0003724_increased_susceptibility_to | 2.22472761 |
14 | MP0000569_abnormal_digit_pigmentation | 2.05600988 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.05234336 |
16 | MP0001661_extended_life_span | 2.04576597 |
17 | MP0005375_adipose_tissue_phenotype | 2.01284472 |
18 | MP0002118_abnormal_lipid_homeostasis | 1.92081511 |
19 | MP0008260_abnormal_autophagy | 1.91184956 |
20 | MP0003045_fibrosis | 1.87804847 |
21 | MP0004381_abnormal_hair_follicle | 1.83934649 |
22 | MP0005334_abnormal_fat_pad | 1.81999500 |
23 | MP0000609_abnormal_liver_physiology | 1.77054498 |
24 | MP0002138_abnormal_hepatobiliary_system | 1.70697609 |
25 | MP0002254_reproductive_system_inflammat | 1.70521498 |
26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70320373 |
27 | MP0006082_CNS_inflammation | 1.69249650 |
28 | MP0003300_gastrointestinal_ulcer | 1.64264504 |
29 | MP0002148_abnormal_hypersensitivity_rea | 1.60984151 |
30 | MP0000465_gastrointestinal_hemorrhage | 1.60176338 |
31 | MP0003868_abnormal_feces_composition | 1.59694402 |
32 | MP0009115_abnormal_fat_cell | 1.59580497 |
33 | MP0002132_abnormal_respiratory_system | 1.59349186 |
34 | MP0009764_decreased_sensitivity_to | 1.56121052 |
35 | MP0000383_abnormal_hair_follicle | 1.55384519 |
36 | MP0002398_abnormal_bone_marrow | 1.54239395 |
37 | MP0001790_abnormal_immune_system | 1.49648987 |
38 | MP0005387_immune_system_phenotype | 1.49648987 |
39 | MP0005058_abnormal_lysosome_morphology | 1.48755456 |
40 | MP0001851_eye_inflammation | 1.46237068 |
41 | MP0003172_abnormal_lysosome_physiology | 1.42660094 |
42 | MP0003656_abnormal_erythrocyte_physiolo | 1.42650066 |
43 | MP0004019_abnormal_vitamin_homeostasis | 1.41699284 |
44 | MP0010234_abnormal_vibrissa_follicle | 1.40268734 |
45 | MP0002405_respiratory_system_inflammati | 1.39689633 |
46 | MP0001666_abnormal_nutrient_absorption | 1.39386592 |
47 | MP0002166_altered_tumor_susceptibility | 1.38677975 |
48 | MP0000716_abnormal_immune_system | 1.37967585 |
49 | MP0003436_decreased_susceptibility_to | 1.36921791 |
50 | MP0000858_altered_metastatic_potential | 1.36565346 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.36516083 |
52 | MP0003183_abnormal_peptide_metabolism | 1.36515428 |
53 | MP0001545_abnormal_hematopoietic_system | 1.35099926 |
54 | MP0005397_hematopoietic_system_phenotyp | 1.35099926 |
55 | MP0003828_pulmonary_edema | 1.34379413 |
56 | MP0001800_abnormal_humoral_immune | 1.33593248 |
57 | MP0001835_abnormal_antigen_presentation | 1.30439595 |
58 | MP0002419_abnormal_innate_immunity | 1.27819416 |
59 | MP0005083_abnormal_biliary_tract | 1.27230553 |
60 | MP0002722_abnormal_immune_system | 1.26083116 |
61 | MP0000689_abnormal_spleen_morphology | 1.25510005 |
62 | MP0003866_abnormal_defecation | 1.21976840 |
63 | MP0005647_abnormal_sex_gland | 1.19234638 |
64 | MP0005535_abnormal_body_temperature | 1.18722711 |
65 | MP0004883_abnormal_blood_vessel | 1.18392084 |
66 | MP0003075_altered_response_to | 1.17929144 |
67 | MP0005166_decreased_susceptibility_to | 1.17290753 |
68 | MP0002006_tumorigenesis | 1.17087997 |
69 | MP0002009_preneoplasia | 1.16764558 |
70 | MP0002429_abnormal_blood_cell | 1.16324428 |
71 | MP0010352_gastrointestinal_tract_polyps | 1.16221054 |
72 | MP0000427_abnormal_hair_cycle | 1.15316562 |
73 | MP0010678_abnormal_skin_adnexa | 1.14628749 |
74 | MP0009763_increased_sensitivity_to | 1.13586074 |
75 | MP0008961_abnormal_basal_metabolism | 1.12305688 |
76 | MP0000579_abnormal_nail_morphology | 1.11140860 |
77 | MP0005332_abnormal_amino_acid | 1.10624477 |
78 | MP0002060_abnormal_skin_morphology | 1.10460057 |
79 | MP0000703_abnormal_thymus_morphology | 1.10197240 |
80 | MP0003950_abnormal_plasma_membrane | 1.09844162 |
81 | MP0009785_altered_susceptibility_to | 1.09763921 |
82 | MP0008004_abnormal_stomach_pH | 1.09357672 |
83 | MP0005025_abnormal_response_to | 1.08593607 |
84 | MP0002168_other_aberrant_phenotype | 1.08264068 |
85 | MP0002970_abnormal_white_adipose | 1.07945860 |
86 | MP0003303_peritoneal_inflammation | 1.07769001 |
87 | MP0005164_abnormal_response_to | 1.06807387 |
88 | MP0004510_myositis | 1.05016719 |
89 | MP0002876_abnormal_thyroid_physiology | 1.03522042 |
90 | MP0003690_abnormal_glial_cell | 1.02957808 |
91 | MP0004808_abnormal_hematopoietic_stem | 1.02552103 |
92 | MP0003806_abnormal_nucleotide_metabolis | 1.02450114 |
93 | MP0002723_abnormal_immune_serum | 1.00883875 |
94 | MP0002452_abnormal_antigen_presenting | 0.99869829 |
95 | MP0003705_abnormal_hypodermis_morpholog | 0.98985862 |
96 | MP0004264_abnormal_extraembryonic_tissu | 0.98976802 |
97 | MP0005409_darkened_coat_color | 0.97979490 |
98 | MP0004947_skin_inflammation | 0.97188757 |
99 | MP0006138_congestive_heart_failure | 0.96677335 |
100 | MP0010155_abnormal_intestine_physiology | 0.96152540 |
101 | MP0008469_abnormal_protein_level | 0.95879399 |
102 | MP0000003_abnormal_adipose_tissue | 0.94104282 |
103 | MP0005464_abnormal_platelet_physiology | 0.92950287 |
104 | MP0009643_abnormal_urine_homeostasis | 0.92893479 |
105 | MP0005448_abnormal_energy_balance | 0.92496192 |
106 | MP0002877_abnormal_melanocyte_morpholog | 0.91826778 |
107 | MP0003566_abnormal_cell_adhesion | 0.91181872 |
108 | MP0000685_abnormal_immune_system | 0.89692826 |
109 | MP0002078_abnormal_glucose_homeostasis | 0.89686613 |
110 | MP0003091_abnormal_cell_migration | 0.89104805 |
111 | MP0005000_abnormal_immune_tolerance | 0.89002562 |
112 | MP0000343_altered_response_to | 0.88959625 |
113 | MP0009278_abnormal_bone_marrow | 0.88566256 |
114 | MP0002396_abnormal_hematopoietic_system | 0.86733843 |
115 | MP0000249_abnormal_blood_vessel | 0.86451406 |
116 | MP0004484_altered_response_of | 0.86413997 |
117 | MP0005167_abnormal_blood-brain_barrier | 0.83540534 |
118 | MP0001873_stomach_inflammation | 0.82658400 |
119 | MP0001853_heart_inflammation | 0.82035047 |
120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81902536 |
121 | MP0009840_abnormal_foam_cell | 0.81745790 |
122 | MP0002837_dystrophic_cardiac_calcinosis | 0.81706114 |
123 | MP0003195_calcinosis | 0.81308015 |
124 | MP0001845_abnormal_inflammatory_respons | 0.81243586 |
125 | MP0005310_abnormal_salivary_gland | 0.80974919 |
126 | MP0001819_abnormal_immune_cell | 0.80719952 |
127 | MP0005319_abnormal_enzyme/_coenzyme | 0.80251173 |
128 | MP0002420_abnormal_adaptive_immunity | 0.80105612 |
129 | MP0001764_abnormal_homeostasis | 0.79740475 |
130 | MP0003453_abnormal_keratinocyte_physiol | 0.77257924 |
131 | MP0002998_abnormal_bone_remodeling | 0.77041524 |
132 | MP0003959_abnormal_lean_body | 0.76519917 |
133 | MP0002136_abnormal_kidney_physiology | 0.75623783 |
134 | MP0002928_abnormal_bile_duct | 0.73360362 |
135 | MP0005671_abnormal_response_to | 0.73207590 |
136 | MP0003646_muscle_fatigue | 0.72645340 |
137 | MP0002933_joint_inflammation | 0.71703019 |
138 | MP0001881_abnormal_mammary_gland | 0.71681561 |
139 | MP0005452_abnormal_adipose_tissue | 0.70927193 |
140 | MP0001879_abnormal_lymphatic_vessel | 0.70710703 |
141 | MP0002796_impaired_skin_barrier | 0.69452556 |
142 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68239687 |
143 | MP0001533_abnormal_skeleton_physiology | 0.67733588 |
144 | MP0003763_abnormal_thymus_physiology | 0.67420678 |
145 | MP0002277_abnormal_respiratory_mucosa | 0.67078743 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of macrophages (HP:0004311) | 3.99319149 |
2 | Deep venous thrombosis (HP:0002625) | 3.76367059 |
3 | Myositis (HP:0100614) | 3.71340176 |
4 | Renal cortical cysts (HP:0000803) | 3.59637499 |
5 | Myocardial infarction (HP:0001658) | 3.55129093 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 3.46277373 |
7 | Orchitis (HP:0100796) | 3.46089134 |
8 | Joint hemorrhage (HP:0005261) | 3.43296363 |
9 | Hyperglycinuria (HP:0003108) | 3.31941983 |
10 | Hypoalphalipoproteinemia (HP:0003233) | 3.27997402 |
11 | Hypoglycemic coma (HP:0001325) | 3.23719084 |
12 | Complement deficiency (HP:0004431) | 3.23220738 |
13 | Optic neuritis (HP:0100653) | 3.23086731 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.23086731 |
15 | Hyperlipoproteinemia (HP:0010980) | 3.20690247 |
16 | Epidermoid cyst (HP:0200040) | 3.16064724 |
17 | Intrahepatic cholestasis (HP:0001406) | 3.13367690 |
18 | Xanthomatosis (HP:0000991) | 3.11579661 |
19 | Epistaxis (HP:0000421) | 3.04373488 |
20 | Gastrointestinal infarctions (HP:0005244) | 3.03586932 |
21 | Obstructive lung disease (HP:0006536) | 2.99987829 |
22 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99987829 |
23 | Abnormality of the fingertips (HP:0001211) | 2.96040678 |
24 | Abnormality of proline metabolism (HP:0010907) | 2.90269390 |
25 | Hydroxyprolinuria (HP:0003080) | 2.90269390 |
26 | Meningitis (HP:0001287) | 2.86885385 |
27 | Polycythemia (HP:0001901) | 2.86883589 |
28 | Increased IgE level (HP:0003212) | 2.84706932 |
29 | Cellulitis (HP:0100658) | 2.82818781 |
30 | Hypertriglyceridemia (HP:0002155) | 2.78858115 |
31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.76599923 |
32 | Petechiae (HP:0000967) | 2.75405059 |
33 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75178783 |
34 | Pigmentary retinal degeneration (HP:0001146) | 2.74604712 |
35 | Vasculitis (HP:0002633) | 2.74551642 |
36 | Colitis (HP:0002583) | 2.71513337 |
37 | Purpura (HP:0000979) | 2.70345196 |
38 | Eczematoid dermatitis (HP:0000976) | 2.70225271 |
39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.67426059 |
40 | Abnormality of glycine metabolism (HP:0010895) | 2.67426059 |
41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.65678233 |
42 | Mediastinal lymphadenopathy (HP:0100721) | 2.64671411 |
43 | Osteomyelitis (HP:0002754) | 2.62417013 |
44 | Keratoconjunctivitis sicca (HP:0001097) | 2.61235070 |
45 | Gingival bleeding (HP:0000225) | 2.60347488 |
46 | Stomatitis (HP:0010280) | 2.59260202 |
47 | Ketosis (HP:0001946) | 2.56389728 |
48 | Prostate neoplasm (HP:0100787) | 2.55028749 |
49 | Autoimmune thrombocytopenia (HP:0001973) | 2.51448280 |
50 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.51014480 |
51 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.50971879 |
52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.48828027 |
53 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.46873622 |
54 | Urticaria (HP:0001025) | 2.45979140 |
55 | Gingivitis (HP:0000230) | 2.41424641 |
56 | Arterial thrombosis (HP:0004420) | 2.40745863 |
57 | Pulmonary embolism (HP:0002204) | 2.40642331 |
58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.39452995 |
59 | Abnormality of the renal cortex (HP:0011035) | 2.37098613 |
60 | Inflammation of the large intestine (HP:0002037) | 2.35844725 |
61 | Hypercholesterolemia (HP:0003124) | 2.35433456 |
62 | Recurrent fungal infections (HP:0002841) | 2.35078984 |
63 | Hemorrhage of the eye (HP:0011885) | 2.34913209 |
64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34881992 |
65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34881992 |
66 | Encephalitis (HP:0002383) | 2.32003708 |
67 | Gastrointestinal stroma tumor (HP:0100723) | 2.31558116 |
68 | Upper limb muscle weakness (HP:0003484) | 2.31531373 |
69 | Interstitial pulmonary disease (HP:0006530) | 2.29704196 |
70 | Acanthosis nigricans (HP:0000956) | 2.26482323 |
71 | Increased mean platelet volume (HP:0011877) | 2.26135679 |
72 | Esophageal varix (HP:0002040) | 2.26082244 |
73 | Chromsome breakage (HP:0040012) | 2.25196875 |
74 | Keratoconjunctivitis (HP:0001096) | 2.23587092 |
75 | Chest pain (HP:0100749) | 2.23361450 |
76 | Fatigue (HP:0012378) | 2.23074209 |
77 | Congenital stationary night blindness (HP:0007642) | 2.21079909 |
78 | Hyperammonemia (HP:0001987) | 2.19427293 |
79 | Amyloidosis (HP:0011034) | 2.18877841 |
80 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17631171 |
81 | Recurrent viral infections (HP:0004429) | 2.15282192 |
82 | Hypolipoproteinemia (HP:0010981) | 2.14543870 |
83 | Pulmonary infiltrates (HP:0002113) | 2.13395606 |
84 | Hyperkalemia (HP:0002153) | 2.13375944 |
85 | Pustule (HP:0200039) | 2.11476938 |
86 | Distal lower limb muscle weakness (HP:0009053) | 2.08561922 |
87 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.07681193 |
88 | Agammaglobulinemia (HP:0004432) | 2.07411488 |
89 | Autoimmune hemolytic anemia (HP:0001890) | 2.07349735 |
90 | Episodic fever (HP:0001954) | 2.05549677 |
91 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.04598960 |
92 | Abnormality of complement system (HP:0005339) | 2.04307835 |
93 | T lymphocytopenia (HP:0005403) | 2.03855395 |
94 | Impaired platelet aggregation (HP:0003540) | 2.03731600 |
95 | Abnormal platelet function (HP:0011869) | 2.03731600 |
96 | Malnutrition (HP:0004395) | 2.03521409 |
97 | Gastrointestinal inflammation (HP:0004386) | 2.03512284 |
98 | Tetraparesis (HP:0002273) | 2.03408235 |
99 | Increased serum ferritin (HP:0003281) | 2.02868454 |
100 | Pancreatitis (HP:0001733) | 2.02804149 |
101 | Aplasia cutis congenita (HP:0001057) | 2.02651306 |
102 | Duplicated collecting system (HP:0000081) | 1.99804610 |
103 | Distal lower limb amyotrophy (HP:0008944) | 1.99512722 |
104 | Slow saccadic eye movements (HP:0000514) | 1.99155624 |
105 | Anorexia (HP:0002039) | 1.98314998 |
106 | Abnormality of the common coagulation pathway (HP:0010990) | 1.98259089 |
107 | Ketoacidosis (HP:0001993) | 1.98229889 |
108 | Hemoptysis (HP:0002105) | 1.98029550 |
109 | Difficulty running (HP:0009046) | 1.97776766 |
110 | Anal stenosis (HP:0002025) | 1.97719139 |
111 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.97133682 |
112 | Joint swelling (HP:0001386) | 1.96119573 |
113 | Dicarboxylic aciduria (HP:0003215) | 1.95790405 |
114 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.95790405 |
115 | Thick nail (HP:0001805) | 1.95486397 |
116 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93978921 |
117 | Muscle fiber splitting (HP:0003555) | 1.93269546 |
118 | Abnormality of T cell number (HP:0011839) | 1.92301874 |
119 | Abnormality of T cells (HP:0002843) | 1.91796137 |
120 | Prolonged bleeding time (HP:0003010) | 1.91750327 |
121 | Periodontitis (HP:0000704) | 1.91659541 |
122 | Oligomenorrhea (HP:0000876) | 1.91256390 |
123 | Microcytic anemia (HP:0001935) | 1.90851823 |
124 | Hypoglycemic seizures (HP:0002173) | 1.90698809 |
125 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90505354 |
126 | Recurrent bacterial skin infections (HP:0005406) | 1.90076101 |
127 | Hyporeflexia of lower limbs (HP:0002600) | 1.89967037 |
128 | Asymmetric septal hypertrophy (HP:0001670) | 1.88967523 |
129 | Recurrent skin infections (HP:0001581) | 1.88118583 |
130 | Recurrent abscess formation (HP:0002722) | 1.87267369 |
131 | Hyperglycemia (HP:0003074) | 1.86924698 |
132 | Thrombophlebitis (HP:0004418) | 1.86810471 |
133 | Chronic diarrhea (HP:0002028) | 1.86801473 |
134 | Abnormality of iron homeostasis (HP:0011031) | 1.86746958 |
135 | Systemic lupus erythematosus (HP:0002725) | 1.85642108 |
136 | Acute hepatic failure (HP:0006554) | 1.85480730 |
137 | Seborrheic dermatitis (HP:0001051) | 1.85252257 |
138 | Gangrene (HP:0100758) | 1.84760454 |
139 | Nephritis (HP:0000123) | 1.83511207 |
140 | Enlarged kidneys (HP:0000105) | 1.83406572 |
141 | Menorrhagia (HP:0000132) | 1.82059636 |
142 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.82016212 |
143 | Granulocytopenia (HP:0001913) | 1.81793528 |
144 | Panhypogammaglobulinemia (HP:0003139) | 1.81441415 |
145 | Hepatosplenomegaly (HP:0001433) | 1.81012202 |
146 | Spontaneous hematomas (HP:0007420) | 1.80245144 |
147 | Osteolytic defects of the hand bones (HP:0009699) | 1.80031492 |
148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80031492 |
149 | Acanthocytosis (HP:0001927) | 1.79929008 |
150 | Acne (HP:0001061) | 1.79037676 |
151 | Ventricular fibrillation (HP:0001663) | 1.77553930 |
152 | Abnormality of purine metabolism (HP:0004352) | 1.77028311 |
153 | Abnormal platelet volume (HP:0011876) | 1.76904465 |
154 | Increased CSF protein (HP:0002922) | 1.76205063 |
155 | Exercise-induced myalgia (HP:0003738) | 1.76174167 |
156 | Fair hair (HP:0002286) | 1.75889797 |
157 | Abnormality of nucleobase metabolism (HP:0010932) | 1.75654238 |
158 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75338170 |
159 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.75097172 |
160 | Skin ulcer (HP:0200042) | 1.74954782 |
161 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74715717 |
162 | Recurrent sinusitis (HP:0011108) | 1.74235023 |
163 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.72906092 |
164 | Tubulointerstitial nephritis (HP:0001970) | 1.71499851 |
165 | Hyperglycinemia (HP:0002154) | 1.71179787 |
166 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.69928412 |
167 | Skin nodule (HP:0200036) | 1.69477117 |
168 | Lip pit (HP:0100267) | 1.68958788 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CAMK1D | 4.01361135 |
2 | CAMK1G | 3.30669098 |
3 | INSRR | 3.23620069 |
4 | PRPF4B | 3.20250550 |
5 | SIK1 | 3.11304456 |
6 | TAOK3 | 2.62206245 |
7 | MAP2K3 | 2.56875627 |
8 | IRAK3 | 2.23257254 |
9 | MAP3K13 | 2.09831339 |
10 | MAP3K14 | 2.09740772 |
11 | JAK1 | 1.96470229 |
12 | FGFR4 | 1.93571840 |
13 | PRKAA2 | 1.90315717 |
14 | LATS1 | 1.88514873 |
15 | MAP3K2 | 1.81815780 |
16 | TXK | 1.78936670 |
17 | KSR2 | 1.78680040 |
18 | BLK | 1.75868060 |
19 | MAP3K1 | 1.71788324 |
20 | MAP3K3 | 1.63281988 |
21 | MAP4K1 | 1.59750140 |
22 | CDK12 | 1.58376863 |
23 | GRK1 | 1.53384055 |
24 | YES1 | 1.50988206 |
25 | TYK2 | 1.50122021 |
26 | NUAK1 | 1.44363017 |
27 | JAK3 | 1.43436367 |
28 | FGFR3 | 1.42611800 |
29 | ERN1 | 1.38796460 |
30 | IKBKE | 1.37207157 |
31 | BRD4 | 1.30416867 |
32 | MAP3K7 | 1.28964745 |
33 | DMPK | 1.25865577 |
34 | EPHB1 | 1.23973634 |
35 | CDK9 | 1.23773618 |
36 | RIPK1 | 1.22368711 |
37 | IRAK4 | 1.21319130 |
38 | MST1R | 1.18318938 |
39 | SIK2 | 1.17587622 |
40 | TGFBR2 | 1.16829103 |
41 | FRK | 1.14782101 |
42 | PIK3CG | 1.14154771 |
43 | EPHA3 | 1.09186045 |
44 | SIK3 | 1.08524845 |
45 | FGFR2 | 1.08168815 |
46 | RIPK4 | 1.08018602 |
47 | BCKDK | 1.06944574 |
48 | CSK | 1.06591812 |
49 | TEC | 1.02015373 |
50 | TAOK1 | 0.99931422 |
51 | FGR | 0.98188281 |
52 | STK3 | 0.97798813 |
53 | HCK | 0.95579079 |
54 | ITK | 0.91821314 |
55 | MAP3K6 | 0.91133026 |
56 | PRKAA1 | 0.88495704 |
57 | MAP3K12 | 0.87193142 |
58 | PIK3CA | 0.86924991 |
59 | NLK | 0.86704548 |
60 | TNIK | 0.85958763 |
61 | MARK2 | 0.85747965 |
62 | TIE1 | 0.85156757 |
63 | PRKCQ | 0.84687238 |
64 | RAF1 | 0.83887824 |
65 | ACVR1B | 0.83556694 |
66 | LRRK2 | 0.83114004 |
67 | SGK3 | 0.80791142 |
68 | JAK2 | 0.80371596 |
69 | PKN1 | 0.79865925 |
70 | RET | 0.78033480 |
71 | IRAK1 | 0.75774297 |
72 | SMG1 | 0.74112323 |
73 | ZAK | 0.73861027 |
74 | MAPK7 | 0.73385764 |
75 | PTK6 | 0.71384219 |
76 | TRIB3 | 0.71287757 |
77 | STK4 | 0.70949126 |
78 | TBK1 | 0.70928909 |
79 | STK10 | 0.70375870 |
80 | FES | 0.70277245 |
81 | IKBKB | 0.70274921 |
82 | PRKD2 | 0.69958717 |
83 | MATK | 0.69631982 |
84 | LCK | 0.68730082 |
85 | CDK6 | 0.67562052 |
86 | CHUK | 0.67334768 |
87 | SGK2 | 0.66831918 |
88 | MAPK11 | 0.66461850 |
89 | MAP3K11 | 0.65060415 |
90 | SCYL2 | 0.62827971 |
91 | PDGFRB | 0.61575295 |
92 | MST4 | 0.60156673 |
93 | CDK4 | 0.59481639 |
94 | OBSCN | 0.59378738 |
95 | STK11 | 0.58534174 |
96 | PRKG2 | 0.58015764 |
97 | SGK1 | 0.57767533 |
98 | STK24 | 0.57357761 |
99 | TAOK2 | 0.56097929 |
100 | TRPM7 | 0.55621263 |
101 | ZAP70 | 0.55425400 |
102 | KIT | 0.54371320 |
103 | LMTK2 | 0.53933555 |
104 | EEF2K | 0.53912191 |
105 | HIPK2 | 0.53828026 |
106 | TTN | 0.53691222 |
107 | BTK | 0.52806652 |
108 | PRKCH | 0.52617635 |
109 | MYLK | 0.52576249 |
110 | MAPK12 | 0.51560983 |
111 | CAMK1 | 0.51528640 |
112 | MARK3 | 0.50865701 |
113 | MAP2K6 | 0.50530515 |
114 | BMPR2 | 0.50476890 |
115 | MAP3K10 | 0.50004149 |
116 | IGF1R | 0.49508277 |
117 | MTOR | 0.49492844 |
118 | TNK2 | 0.49340749 |
119 | STK38L | 0.48430297 |
120 | WNK1 | 0.48077598 |
121 | PDPK1 | 0.48040500 |
122 | BMX | 0.47649205 |
123 | IRAK2 | 0.46885650 |
124 | KSR1 | 0.46242162 |
125 | CSF1R | 0.45811712 |
126 | ABL1 | 0.45725834 |
127 | LYN | 0.45337359 |
128 | PDK1 | 0.43143840 |
129 | SYK | 0.43030514 |
130 | PKN2 | 0.42561917 |
131 | PIM1 | 0.42476638 |
132 | GRK6 | 0.41794846 |
133 | PDK2 | 0.41537144 |
134 | NEK9 | 0.41062259 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.67053319 |
2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55623670 |
3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.45747455 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43843049 |
5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.42272352 |
6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39855064 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32366504 |
8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.28390849 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22263691 |
10 | Lysine degradation_Homo sapiens_hsa00310 | 2.10667661 |
11 | ABC transporters_Homo sapiens_hsa02010 | 2.09049552 |
12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08706291 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07992393 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07865259 |
15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84675794 |
16 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.79949128 |
17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.74106159 |
18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69956707 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68645344 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.65152691 |
21 | Tuberculosis_Homo sapiens_hsa05152 | 1.63490366 |
22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58015111 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.55533337 |
24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.49320100 |
25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49149266 |
26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46511532 |
27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46304641 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38769961 |
29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.34907263 |
30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31402119 |
31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28182006 |
32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24099188 |
33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23261708 |
34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20622052 |
35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19071895 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18615710 |
37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18006019 |
38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15615146 |
39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14485507 |
40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13722489 |
41 | Insulin resistance_Homo sapiens_hsa04931 | 1.13676241 |
42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13442673 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12348011 |
44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.09755356 |
45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09698386 |
46 | Legionellosis_Homo sapiens_hsa05134 | 1.09373444 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08639574 |
48 | Bile secretion_Homo sapiens_hsa04976 | 1.04304616 |
49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00801025 |
50 | Hepatitis B_Homo sapiens_hsa05161 | 0.99321788 |
51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98516453 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98357470 |
53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96237092 |
54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95343186 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95153753 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94999737 |
57 | Asthma_Homo sapiens_hsa05310 | 0.93083891 |
58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92425112 |
59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92048932 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91730764 |
61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89787393 |
62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87648567 |
63 | Pertussis_Homo sapiens_hsa05133 | 0.84830842 |
64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83458883 |
65 | Phagosome_Homo sapiens_hsa04145 | 0.83398136 |
66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83382796 |
67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82325982 |
68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80679911 |
69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79245253 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78462048 |
71 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75630660 |
72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74722813 |
73 | Measles_Homo sapiens_hsa05162 | 0.74720472 |
74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73168123 |
75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72637787 |
76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71318395 |
77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69878525 |
78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69857251 |
79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69661981 |
80 | Amoebiasis_Homo sapiens_hsa05146 | 0.69370270 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68925096 |
82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68343025 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67728995 |
84 | Shigellosis_Homo sapiens_hsa05131 | 0.67328976 |
85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67080600 |
86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65664972 |
87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65093337 |
88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64969539 |
89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63227538 |
90 | Malaria_Homo sapiens_hsa05144 | 0.60271396 |
91 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59760588 |
92 | Apoptosis_Homo sapiens_hsa04210 | 0.59594501 |
93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58921724 |
94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58888836 |
95 | Lysosome_Homo sapiens_hsa04142 | 0.58700753 |
96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58637766 |
97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57772866 |
98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57302415 |
99 | Endocytosis_Homo sapiens_hsa04144 | 0.57222607 |
100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56004996 |
101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55609971 |
102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55117462 |
103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54890706 |
104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54877395 |
105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54519185 |
106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53808888 |
107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53279460 |
108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52714714 |
109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52211799 |
110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50528295 |
111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50315590 |
112 | Salmonella infection_Homo sapiens_hsa05132 | 0.50264698 |
113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50015411 |
114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48923881 |
115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48692951 |
116 | Prostate cancer_Homo sapiens_hsa05215 | 0.48679071 |
117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48582233 |
118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48325230 |
119 | Glioma_Homo sapiens_hsa05214 | 0.47930025 |
120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47837994 |
121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47819041 |
122 | Hepatitis C_Homo sapiens_hsa05160 | 0.47176817 |
123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45849039 |
124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45519523 |
125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45157352 |
126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44790673 |
127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44155979 |
128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43431797 |
129 | Influenza A_Homo sapiens_hsa05164 | 0.43259983 |
130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43235797 |
131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43215139 |
132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42453750 |
133 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42320797 |
134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42291807 |
135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39446348 |
136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37473892 |
137 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.36445576 |
138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36161426 |
139 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35399484 |
140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35168644 |
141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35086967 |
142 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34227762 |
143 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.34146845 |
144 | Renin secretion_Homo sapiens_hsa04924 | 0.32262633 |
145 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31891329 |
146 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31664711 |
147 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31558556 |
148 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30944721 |
149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30553676 |
150 | Platelet activation_Homo sapiens_hsa04611 | 0.27825777 |
151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27382587 |